Chen et al. found that berberine inhibited inflammatory cancer transformation of CRC by modulating mitofusin-2 (MFN2) to reduce colitis exacerbated by obesity [126]. The gene discussed is MFN2; the disease is obesity due to melanocortin 4 receptor deficiency.